Download PDF
Planta Med 2014; 80(02/03): 109-120
DOI: 10.1055/s-0033-1351019
Reviews
Georg Thieme Verlag KG Stuttgart · New York

Topical Application of St. Johnʼs Wort (Hypericum perforatum)

Ute Wölfle
1   Section skintegral, Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
,
Günter Seelinger
2   Medical Services Dr. Seelinger, Berlin, Germany
,
Christoph M. Schempp
1   Section skintegral, Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
› Author Affiliations
Further Information

Publication History

received 28 June 2013
revised 26 September 2013

accepted 27 September 2013

Publication Date:
08 November 2013 (online)

   Permissions and Reprints

Abstract

St. Johnʼs wort (Hypericum perforatum) has been intensively investigated for its antidepressive activity, but dermatological applications also have a long tradition. Topical St. Johnʼs wort preparations such as oils or tinctures are used for the treatment of minor wounds and burns, sunburns, abrasions, bruises, contusions, ulcers, myalgia, and many others. Pharmacological research supports the use in these fields. Of the constituents, naphthodianthrones (e.g., hypericin) and phloroglucinols (e.g., hyperforin) have interesting pharmacological profiles, including antioxidant, anti-inflammatory, anticancer, and antimicrobial activities. In addition, hyperforin stimulates growth and differentiation of keratinocytes, and hypericin is a photosensitizer which can be used for selective treatment of nonmelanoma skin cancer. However, clinical research in this field is still scarce. Recently, sporadic trials have been conducted in wound healing, atopic dermatitis, psoriasis, and herpes simplex infections, partly with purified single constituents and modern dermatological formulations. St. Johnʼs wort also has a potential for use in medical skin care. Composition and stability of pharmaceutical formulations vary greatly depending on origin of the plant material, production method, lipophilicity of solvents, and storage conditions, and this must be regarded with respect to practical as well as scientific purposes.

Key words

St. Johnʼs wort - Hypericum perforatum - Hypericaceae - topical application - dermatology
 

  • References

  • 1 Pliny the Elder (23-79 A.D.). The natural history. Book XXVI, Chapter LXXX. Cited after: Bostock J, Riley HT, editors. London: Taylor and Francis; 1855. The perseus digital library. Available at: http://www.perseus.tufts.edu/hopper/text?doc=Perseus%253atext%253a1999.02.0137 Accessed April 5, 2013
    PubMedGoogle Scholar
  • 2 Blaschek W, Ebel S, Hackenthal E, Holzgrabe U, Keller K, Reichling J, Schulz V. Hagers Handbuch der pharmazeutischen Praxis. Berlin, Heidelberg: Springer Verlag; 2008
    Google Scholar
  • 3 WHO. WHO-Monographs on selected medical plants. Geneva: World Health Organization; 2002
    Google Scholar
  • 4 EMEA (European Medicines Agency). HMPC Community herbal monograph on Hypericum perforatum L., herba (Traditional use). EMEA/HMPC/745582/2009. Wien Med Wochenschr 2010; 160: 557-563
    CrossrefPubMedGoogle Scholar
  • 5 Isacchi B, Bergonzi MC, Carnevali F, van der Esch SA, Vincieri FF, Bilia AR. Analysis and stability of the constituents of St. Johnʼs wort oils prepared with different methods. J Pharm Biomed Anal 2007; 45: 756-761
    CrossrefPubMedGoogle Scholar
  • 6 German Pharmacopoeia, EB6 (Deutsches Arzneibuch. Suppl., 6th edition). Bonn: Phytopharmaceutical Corporation; 1941: 409
    Google Scholar
  • 7 Schmidt AH. Use of an on-line, precolumn photochemical reactor in high-performance liquid chromatography of naphthodianthrones in Hypericum perforatum preparations. J Chromatogr A 2003; 987: 181-187
    PubMedGoogle Scholar
  • 8 Maisenbacher P, Kovar KA. Analysis and stability of Hyperici oleum . Planta Med 1992; 58: 351-354
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Verotta L, Appendino G, Jakupovic J, Bombardelli E. Hyperforin analogues from St. Johnʼs wort (Hypericum perforatum). J Nat Prod 2000; 63: 412-415
    CrossrefPubMedGoogle Scholar
  • 10 Arsić I, Zugić A, Tadić V, Tasić-Kostov M, Mišić D, Primorac M, Runjaić-Antić D. Estimation of dermatological application of creams with St. Johnʼs Wort oil extracts. Molecules 2011; 17: 275-294
    CrossrefPubMedGoogle Scholar
  • 11 Orhan IE, Kartal M, Gülpinar AR, Cos P, Matheeussen A, Maes L, Tasdemir D. Assessment of antimicrobial and antiprotozoal activity of the olive oil macerate samples of Hypericum perforatum and their LC-DAD-MS analyses. Food Chem 2013; 138: 870-875
    CrossrefPubMedGoogle Scholar
  • 12 EMEA (European Medicines Agency). HMPC assessment report on Hypericum perforatum L., Herba. EMA/HMPC/101303/2008. London: EMEA; 2009
    CrossrefGoogle Scholar
  • 13 Gaedcke F. Herstell- und Qualitätsaspekte pflanzlicher Extrakte. Pharmazie in unserer Zeit 2003; 3: 192-202
    PubMedGoogle Scholar
  • 14 Kacerovská D, Pizinger K, Majer F, Smíd F. Photodynamic therapy of nonmelanoma skin cancer with topical Hypericum perforatum extract–a pilot study. Photochem Photobiol 2008; 84: 779-785
    CrossrefPubMedGoogle Scholar
  • 15 Tardivo JP, Wainwright M, Baptista MS. Local clinical phototreatment of herpes infection in São Paulo. Photodiagnosis Photodyn Ther 2012; 9: 118-121
    CrossrefPubMedGoogle Scholar
  • 16 Schempp CM, Lüdtke R, Winghofer B, Simon JC. Effect of topical application of Hypericum perforatum extract (St. Johnʼs wort) on skin sensitivity to solar simulated radiation. Photodermatol Photoimmunol Photomed 2000; 16: 125-128
    CrossrefPubMedGoogle Scholar
  • 17 Schempp CM, Windeck T, Hezel S, Simon JC. Topical treatment of atopic dermatitis with St. Johnʼs wort cream – a randomized, placebo controlled, double blind half-side comparison. Phytomedicine 2003; 10 (Suppl. 04) 31-37
    CrossrefPubMedGoogle Scholar
  • 18 Cecchini C, Cresci A, Coman MM, Ricciutelli M, Sagratini G, Vittori S, Lucarini D, Maggi F. Antimicrobial activity of seven Hypericum entities from central Italy. Planta Med 2007; 73: 564-566
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Gibbons S, Ohlendorf B, Johnsen I. The genus Hypericum – a valuable resource of anti-Staphylococcal leads. Fitoterapia 2002; 73: 300-304
    CrossrefPubMedGoogle Scholar
  • 20 Bystrov NS, Dobrynin VN, Kolosov MN, Chernov BK, Chervin II. [Structure of the chromophoric part of hyperforin]. Dokl Akad Nauk SSSR 1975; 225: 1327-1328
    PubMedGoogle Scholar
  • 21 Schempp CM, Pelz K, Wittmer A, Schöpf E, Simon JC. Antibacterial activity of hyperforin from St Johnʼs wort, against multiresistant Staphylococcus aureus and gram-positive bacteria. Lancet 1999; 353: 2129
    PubMedGoogle Scholar
  • 22 Yow CM, Tang HM, Chu ES, Huang Z. Hypericin-mediated photodynamic antimicrobial effect on clinically isolated pathogens. Photochem Photobiol 2012; 88: 626-632
    CrossrefPubMedGoogle Scholar
  • 23 Borchardt JR, Wyse DL, Sheaffer CC, Kauppi KL, Fulcher RG, Ehlke NG, Bicsboer DD, Bey RF. Antimicrobial activity of native and naturalized plants of Minnesota and Wisconsin. J Med Plants Res 2008; 2: 98-110
    PubMedGoogle Scholar
  • 24 Avato P, Raffo F, Guglielmi G, Vitali C, Rosato A. Extracts from St Johnʼs Wort and their antimicrobial activity. Phytother Res 2004; 18: 230-232
    CrossrefPubMedGoogle Scholar
  • 25 Dadgar T, Asmar M, Saifi A, Mazandarani M, Bayat H, Moradi A, Bazueri M, Ghaemi E. Antibacterial activity of certain medicinal plants against methicillin resistant and methicillin sensitive Staphylococcus aureus . Asian J Plant Sci 2006; 5: 861-866
    CrossrefPubMedGoogle Scholar
  • 26 Lasik M, Nowak J, Stachowiak B, Czarnecki Z. Evaluation of the antagonistic properties of natural antibacterial substances extracted from herbs: poster presentation. Eurobiotech 2007; 54: 10 (cited after Saddiqe 2010)
    PubMedGoogle Scholar
  • 27 Reichling J, Weseler A, Saller R. A current review of the antimicrobial activity of Hypericum perforatum L. Pharmacopsychiatry 2001; 34 (Suppl. 01) S116-S118
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Mortensen T, Shen S, Shen F, Walsh MK, Sims RC, Miller CD. Investigating the effectiveness of St Johnʼs wort herb as an antimicrobial agent against Mycobacteria . Phytother Res 2012; 26: 1327-1333
    CrossrefPubMedGoogle Scholar
  • 29 Peeva-Naumovska V, Panovski N, Grdanovska T, Fredro-Kumbaradzi E. Formulations of St. Johnʼs Wort oil ointment and evaluation of its antibacterial effect. Available at http://www.amapseec.org/cmapseec.1/papers/pap-p067.htm 2000. Accessed April 28, 2013
    PubMedGoogle Scholar
  • 30 Saddiqe Z, Naeem I, Maimoona A. A review of the antibacterial activity of Hypericum perforatum L. J Ethnopharmacol 2010; 131: 511-521
    CrossrefPubMedGoogle Scholar
  • 31 Birt DF, Widrlechner MP, Hammer KD, Hillwig ML, Wei J, Kraus GA, Murphy PA, McCoy J, Wurtele ES, Neighbors JD, Wiemer DF, Maury WJ, Price JP. Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents. Pharm Biol 2009; 47: 774-782
    CrossrefPubMedGoogle Scholar
  • 32 Klemow KM, Bartlow A, Crawford J, Kocher N, Shah J, Ritsick M. Medical attributes of St. Johnʼs Wort (Hypericum perforatum). In: Benzie IFF, Wachtel-Galor S, editors Herbal medicine: biomolecular and clinical aspects. 2nd edition. Boca Raton: CRC Press; 2011. (Chapter 11)
    CrossrefGoogle Scholar
  • 33 Takahashi I, Nakanishi S, Kobayashi E, Nakano H, Suzuki K, Tamaoki T. Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity. Biochem Biophys Res Commun 1989; 165: 1207-1212
    CrossrefPubMedGoogle Scholar
  • 34 Gulick RM, McAuliffe V, Holden-Wiltse J, Crumpacker C, Liebes L, Stein DS, Meehan P, Hussey S, Forcht J, Valentine FT. Phase I studies of hypericin, the active compound in St. Johnʼs Wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med 1999; 130: 510-514
    CrossrefPubMedGoogle Scholar
  • 35 Maury W, Price JP, Brindley MA, Oh C, Neighbors JD, Wiemer DF, Wills N, Carpenter S, Hauck C, Murphy P, Widrlechner MP, Delate K, Kumar G, Kraus GA, Rizshsky L, Nikolau B. Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum . Virol J 2009; 6: 101
    CrossrefPubMedGoogle Scholar
  • 36 López-Chicón P, Paz-Cristobal MP, Rezusta A, Aspiroz C, Royo-Cañas M, Andres-Ciriano E, Gilaberte Y, Agut M, Nonell S. On the mechanism of Candida spp. photoinactivation by hypericin. Photochem Photobiol Sci 2012; 11: 1099-1107
    CrossrefPubMedGoogle Scholar
  • 37 Khosa RL, Bhatia N. Antifungal effect of Hypericum perforatum Linn. J Sci Res Plant Med 1982; 3: 49-50
    PubMedGoogle Scholar
  • 38 Hunt EJ, Lester CE, Lester EA, Tackett RL. Effect of St. Johnʼs wort on free radical production. Life Sci 2001; 69: 181-190
    CrossrefPubMedGoogle Scholar
  • 39 Benedi J, Arroyo R, Romero C, Martin-Aragon S, Villar AM. Antioxidant properties and protective effects of a standardized extract of Hypericum perforatum on hydrogen peroxide-induced oxidative damage in PC12 cells. Life Sci 2004; 75: 1263-1276
    CrossrefPubMedGoogle Scholar
  • 40 Jang MH, Lee TH, Shin MC, Bahn GH, Kim JW, Shin DH, Kim EH, Kim CJ. Protective effect of Hypericum perforatum Linn (St. Johnʼs wort) against hydrogen peroxide-induced apoptosis on human neuroblastoma cells. Neurosci Lett 2002; 329: 177-180
    CrossrefPubMedGoogle Scholar
  • 41 Sagratini G, Ricciutelli M, Vittori S, Oztürk N, Oztürk Y, Maggi F. Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia 2008; 79: 210-213
    CrossrefPubMedGoogle Scholar
  • 42 Rainha N, Lima E, Baptista J. Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile. Nat Prod Res 2011; 25: 123-135
    CrossrefPubMedGoogle Scholar
  • 43 Zou Y, Lu Y, Wei D. Antioxidant activity of a flavonoid-rich extract of Hypericum perforatum L. in vitro . J Agric Food Chem 2004; 52: 5032-5039
    CrossrefPubMedGoogle Scholar
  • 44 Meinke MC, Schanzer S, Haag SF, Casetti F, Müller ML, Wölfle U, Kleemann A, Lademann J, Schempp CM. In vivo photoprotective and anti-inflammatory effect of hyperforin is associated with high antioxidant activity in vitro and ex vivo. Eur J Pharm Biopharm 2012; 81: 346-350
    CrossrefPubMedGoogle Scholar
  • 45 Onoue S, Seto Y, Ochi M, Inoue R, Ito H, Hatano T, Yamada S. In vitro photochemical and phototoxicological characterization of major constituents in St. Johnʼs Wort (Hypericum perforatum) extracts. Phytochemistry 2011; 72: 1814-1820
    CrossrefPubMedGoogle Scholar
  • 46 Schempp CM, Müller K, Winghofer B, Schulte-Mönting J, Simon JC. Single-dose and steady-state administration of Hypericum perforatum extract (St Johnʼs Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. Arch Dermatol 2001; 137: 512-513
    PubMedGoogle Scholar
  • 47 Traynor NJ, Beattie PE, Ibbotson SH, Moseley H, Ferguson J, Woods JA. Photogenotoxicity of hypericin in HaCaT keratinocytes: implications for St. Johnʼs Wort supplements and high dose UVA-1 therapy. Toxicol Lett 2005; 158: 220-224
    CrossrefPubMedGoogle Scholar
  • 48 Schmitt LA, Liu Y, Murphy PA, Petrich JW, Dixon PM, Birt DF. Reduction in hypericin-induced phototoxicity by Hypericum perforatum extracts and pure compounds. J Photochem Photobiol B 2006; 85: 118-130
    CrossrefPubMedGoogle Scholar
  • 49 Boiy A, Roelandts R, van den Oord J, de Witte PA. Photosensitizing activity of hypericin and hypericin acetate after topical application on normal mouse skin. Br J Dermatol 2008; 158: 360-369
    PubMedGoogle Scholar
  • 50 Sosa S, Pace R, Bornancin A, Morazzoni P, Riva A, Tubaro A, Della Loggia R. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J Pharm Pharmacol 2007; 59: 703-709
    CrossrefPubMedGoogle Scholar
  • 51 Kang BY, Chung SW, Kim TS. Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by hpyericin, an active component of Hypericum perforatum . Planta Med 2001; 67: 364-366
    Article in Thieme ConnectPubMedGoogle Scholar
  • 52 Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol 2002; 64: 1767-1775
    CrossrefPubMedGoogle Scholar
  • 53 Hammer KD, Hillwig ML, Solco AK, Dixon PM, Delate K, Murphy PA, Wurtele ES, Birt DF. Inhibition of prostaglandin E(2) production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 Mouse Macrophage Cells. J Agric Food Chem 2007; 55: 7323-7331
    CrossrefPubMedGoogle Scholar
  • 54 Koeberle A, Rossi A, Bauer J, Dehm F, Verotta L, Northoff H, Sautebin L, Werz O. Hyperforin, an Anti-Inflammatory Constituent from St. Johnʼs Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo . Front Pharmacol 2011; 2: 7
    PubMedGoogle Scholar
  • 55 Feisst C, Pergola C, Rakonjac M, Rossi A, Koeberle A, Dodt G, Hoffmann M, Hoernig C, Fischer L, Steinhilber D, Franke L, Schneider G, Rådmark O, Sautebin L, Werz O. Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo . Cell Mol Life Sci 2009; 66: 2759-2771
    CrossrefPubMedGoogle Scholar
  • 56 Heilmann J, Winkelmann K, Sticher O. Studies on the antioxidative activity of phloroglucinol derivatives isolated from Hypericum species. Planta Med 2003; 69: 202-206
    Article in Thieme ConnectPubMedGoogle Scholar
  • 57 Cabrelle A, DellʼAica I, Melchiori L, Carraro S, Brunetta E, Niero R, Scquizzato E, DʼIntino G, Calzà L, Garbisa S, Agostini C. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J Leukoc Biol 2008; 83: 212-219
    PubMedGoogle Scholar
  • 58 Schempp CM, Winghofer B, Lüdtke R, Simon-Haarhaus B, Schöpf E, Simon JC. Topical application of St Johnʼs wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells. Br J Dermatol 2000; 142: 979-984
    CrossrefPubMedGoogle Scholar
  • 59 Schempp CM, Simon-Haarhaus B, Simon JC. Phototoxic and apoptosis-inducing capacity of pseudohypericin. Planta Med 2002; 68: 171-173
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Schempp CM, Simon-Haarhaus B, Termeer CC, Simon JC. Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8. FEBS Lett 2001; 493: 26-30
    CrossrefPubMedGoogle Scholar
  • 61 Sharma KV, Davids LM. Hypericin-PDT-induced rapid necrotic death in human squamous cell carcinoma cultures after multiple treatment. Cell Biol Int 2012; 36: 1261-1266
    CrossrefPubMedGoogle Scholar
  • 62 Sharma KV, Davids LM. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death. Photodiagnosis Photodyn Ther 2012; 9: 156-163
    CrossrefPubMedGoogle Scholar
  • 63 Menichini G, Alfano C, Marrelli M, Toniolo C, Provenzano E, Statti GA, Nicoletti M, Menichini F, Conforti F. Hypericum perforatum L. subsp. perforatum induces inhibition of free radicals and enhanced phototoxicity in human melanoma cells under ultraviolet light. Cell Prolif 2013; 46: 193-202
    CrossrefPubMedGoogle Scholar
  • 64 Huntosova V, Nadova Z, Dzurova L, Jakusova V, Sureau F, Miskovsky P. Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles. Photochem Photobiol Sci 2012; 11: 1428-1436
    CrossrefPubMedGoogle Scholar
  • 65 Ritz R, Scheidle C, Noell S, Roser F, Schenk M, Dietz K, Strauss WSL. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells. PLoS ONE 2012; 7: e51974
    CrossrefPubMedGoogle Scholar
  • 66 Šemeláková M, Mikeš J, Jendželovský R, Fedoročko P. The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells. J Photochem Photobiol B 2012; 117: 115-125
    CrossrefPubMedGoogle Scholar
  • 67 Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC, Gilb B, Kaufmann T, Borner C, Sleeman JP, Simon JC. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. Johnʼs wort that acts by induction of apoptosis. Oncogene 2002; 21: 1242-1250
    CrossrefPubMedGoogle Scholar
  • 68 Merhi F, Tang R, Piedfer M, Mathieu J, Bombarda I, Zaher M, Kolb JP, Billard C, Bauvois B. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells. PLoS One 2011; 6: e25963
    CrossrefPubMedGoogle Scholar
  • 69 Hostanska K, Reichling J, Bommer S, Weber M, Saller R. Hyperforin a constituent of St Johnʼs wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines. Eur J Pharm Biopharm 2003; 56: 121-132
    CrossrefPubMedGoogle Scholar
  • 70 Schempp CM, Kiss J, Kirkin V, Averbeck M, Simon-Haarhaus B, Kremer B, Termeer CC, Sleeman J, Simon JC. Hyperforin acts as an angiogenesis inhibitor. Planta Med 2005; 71: 999-1004
    Article in Thieme ConnectPubMedGoogle Scholar
  • 71 Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol 2012; 143: 383-396
    CrossrefPubMedGoogle Scholar
  • 72 Romagnolo DF, Selmin OI. Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 2012; 31: 206-238
    CrossrefPubMedGoogle Scholar
  • 73 Mukherjee PK, Verpoorte R, Suresh B. Evaluation of in-vivo wound healing activity of Hypericum patulum (Family: Hypericaceae) leaf extract on different wound model in rats. J Ethnopharmacol 2000; 70: 315-321
    CrossrefPubMedGoogle Scholar
  • 74 Süntar IP, Akkol EK, Yilmazer D, Baykal T, Kirmizibekmez H, Alper M, Yeşilada E. Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol 2010; 127: 468-477
    CrossrefPubMedGoogle Scholar
  • 75 Castro FC, Magre A, Cherpinski R, Zelante PM, Neves LM, Esquisatto MA, Mendonça FA, Santos GM. Effects of microcurrent application alone or in combination with topical Hypericum perforatum L. and Arnica montana L. on surgically induced wound healing in Wistar rats. Homeopathy 2012; 101: 147-153
    Article in Thieme ConnectPubMedGoogle Scholar
  • 76 Öztürk N, Korkmaz S, Ozturk Y. Wound-healing activity of St. Johnʼs Wort (Hypericum perforatum L.) on chicken embryonic fibroblasts. J Ethnopharmacol 2006; 111: 33-39
    PubMedGoogle Scholar
  • 77 Hostanska K, Rostock M, Melzer J, Baumgartner S, Saller R. A homeopathic remedy from arnica, marigold, St. Johnʼs wort and comfrey accelerates in vitro wound scratch closure of NIH 3 T3 fibroblasts. BMC Complement Altern Med 2012; 12: 100
    CrossrefPubMedGoogle Scholar
  • 78 Leuner K, Kraus M, Woelfle U, Beschmann H, Harteneck C, Boehncke WH, Schempp CM, Müller WE. Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One 2011; 6: e14716
    CrossrefPubMedGoogle Scholar
  • 79 Müller M, Essin K, Hill K, Beschmann H, Rubant S, Schempp CM, Gollasch M, Boehncke WH, Harteneck C, Müller WE, Leuner K. Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem 2008; 283: 33942-33954
    CrossrefPubMedGoogle Scholar
  • 80 Chen WC, Liou SS, Tzeng TF, Lee SL, Liu IM. Effect of topical application of chlorogenic acid on excision wound healing in rats. Planta Med 2013; Apr 8. [Epub ahead of print]
    PubMedGoogle Scholar
  • 81 CEBM – Oxford Centre for Evidence Based Medicine. Levels of evidence. March 2009. Available at http://www.cebm.net/?o=1025 Accessed April 30, 2013
    PubMedGoogle Scholar
  • 82 Saljic J. Ointment for the treatment of burns. Ger Offen 1975; 2: 406-452
    PubMedGoogle Scholar
  • 83 Lomagno P, Lomagno RC. Activity of Hypericum perforatum oil in the treatment of the bed sores in old people. Fitoterapia 1979; 50: 201-205
    PubMedGoogle Scholar
  • 84 Kundaković T, Milenković M, Zlatković S, Nikolić V, Nikolić G, Binić I. Treatment of venous ulcers with the herbal-based ointment Herbadermal®: a prospective non-randomized pilot study. Forsch Komplementmed 2012; 19: 26-30
    CrossrefPubMedGoogle Scholar
  • 85 Lavagna SM, Secci D, Chimenti P, Bonsignore L, Ottaviani A, Bizzarri B. Efficacy of Hypericum and Calendula oils in the epithelial reconstruction of surgical wounds in childbirth with caesarean section. Farmaco 2001; 56: 451-453
    CrossrefPubMedGoogle Scholar
  • 86 Samadi S, Khadivzadeh T, Emami A, Moosavi NS, Tafaghodi M, Behnam HR. The effect of Hypericum perforatum on the wound healing and scar of cesarean. J Alternat Complement Med 2010; 16: 113-117
    CrossrefPubMedGoogle Scholar
  • 87 Läuchli S, Hafner J, Wehrmann C, French LE, Hunziker T. Post-surgical scalp wounds with exposed bone treated with a plant-derived wound therapeutic. J Wound Care 2012; 21: 228 230, 232–233
    PubMedGoogle Scholar
  • 88 Najafizadeh P, Hashemian F, Mansouri P, Farshi S, Surmaghi MS, Chalangari R. The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study. Australas J Dermatol 2012; 53: 131-135
    CrossrefPubMedGoogle Scholar
  • 89 Mannel M, Koytchev R, Dundarov S. Oral hypericum extract LI 160 is an effective treatment of recurrent herpes genitalis and herpes labialis. Phytomedicine 2000; 7 (Suppl. 02) 17
    PubMedGoogle Scholar
  • 90 Clewell A, Barnes M, Endres JR, Ahmed M, Ghambeer DK. Efficacy and tolerability assessment of a topical formulation containing copper sulfate and Hypericum perforatum on patients with herpes skin lesions: a comparative, randomized controlled trial. J Drugs Dermatol 2012; 11: 209-215
    PubMedGoogle Scholar
  • 91 Alecu M, Ursaciuc C, Hãlãlãu F, Coman G, Merlevede W, Waelkens E, de Witte P. Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin. Anticancer Res 1998; 18: 4651-4654
    PubMedGoogle Scholar
  • 92 Dirschka T and AK-CT002 Study Group. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol 2012; 166: 137-146
    CrossrefPubMedGoogle Scholar
  • 93 Heinrich U, Tronnier H. Wirksamkeit und Verträglichkeit eines Johanniskraut-Extraktes zur Pflege der atopischen Haut. Kosmetische Med 2003; 124: 133-136
    PubMedGoogle Scholar
  • 94 Arndt S, Haag SF, Kleemann A, Lademann J, Meinke MC. Radical protection in the visible and infrared by a hyperforin-rich cream – in vivo versus ex vivo methods. Exp Dermatol 2013; 22: 354-357
    CrossrefPubMedGoogle Scholar
  • 95 Haag SF, Tscherch K, Arndt S, Kleemann A, Gersonde I, Lademann J, Rohn S, Meinke MC. Enhancement of skin radical scavenging activity and stratum corneum lipids after the application of a hyperforin-rich cream. Eur J Pharm Biopharm 2013; Jun 26 [pii: S0939–6411(13)00235-X]. DOI: 10.1016/j.ejpb.2013.06.016. [Epub ahead of print]
    PubMedGoogle Scholar
  • 96 CIR – Cosmetic Ingredient Review. Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil. Int J Toxicol 2001; 20 (Suppl. 02) 31-39
    CrossrefPubMedGoogle Scholar
  • 97 Reuter J, Huyke C, Scheuvens H, Ploch M, Neumann K, Jakob T, Schempp CM. Skin tolerance of a new bath oil containing St. Johnʼs wort extract. Skin Pharmacol Physiol 2008; 21: 306-311
    CrossrefPubMedGoogle Scholar